Cookson Peirce & CO Inc Abb Vie Inc. Transaction History

Cookson Peirce & CO Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	SELL	$144.61 - $166.54 $464,487 - $534,926	-3,212 Reduced 46.44%	3,704 $590,000
Q4 2022 Jan 31, 2023	SELL	$138.31 - $165.87 $189,484 - $227,241	-1,370 Reduced 16.53%	6,916 $1.12 Million
Q3 2022 Nov 08, 2022	BUY	$134.21 - $153.93 $46,436 - $53,259	346 Added 4.36%	8,286 $1.11 Million
Q2 2022 Jul 20, 2022	BUY	$137.62 - $174.96 $121,380 - $154,314	882 Added 12.5%	7,940 $1.22 Million
Q1 2022 May 03, 2022	BUY	$131.98 - $163.75 $233,076 - $289,182	1,766 Added 33.37%	7,058 $1.14 Million
Q4 2021 Jan 31, 2022	BUY	$107.43 - $135.93 $19,659 - $24,875	183 Added 3.58%	5,292 $716,000
Q3 2021 Nov 04, 2021	SELL	$106.4 - $120.78 $36 Million - $40.8 Million	-337,982 Reduced 98.51%	5,109 $551,000
Q2 2021 Aug 03, 2021	BUY	$105.21 - $117.21 $1.21 Million - $1.35 Million	11,531 Added 3.48%	343,091 $38.6 Million
Q1 2021 May 11, 2021	BUY	$102.3 - $112.62 $18.8 Million - $20.7 Million	183,677 Added 124.2%	331,560 $35.9 Million
Q4 2020 Feb 10, 2021	BUY	$80.49 - $108.67 $11.9 Million - $16.1 Million	147,883 New	147,883 $15.8 Million

3,943

1.26B

16.8M

12.1M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $337B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Cookson Peirce & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Cookson Peirce & CO Inc with notifications on news.